Cargando…
p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy
Overexpression of the ErbB2/HER2 receptor tyrosine kinase occurs in up to 20% of human breast cancers and correlates with aggressive disease. Several efficacious targeted therapies, including antibodies and kinase inhibitors, have been developed but the occurring of resistance to these agents is oft...
Autores principales: | Bisaro, Brigitte, Sciortino, Marianna, Colombo, Shana, Leal, Maria Pilar Camacho, Costamagna, Andrea, Castellano, Isabella, Montemurro, Filippo, Rossi, Valentina, Valabrega, Giorgio, Turco, Emilia, Defilippi, Paola, Cabodi, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826217/ https://www.ncbi.nlm.nih.gov/pubmed/26716506 http://dx.doi.org/10.18632/oncotarget.6710 |
Ejemplares similares
-
Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion
por: Sciortino, Marianna, et al.
Publicado: (2017) -
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents
por: Costamagna, Andrea, et al.
Publicado: (2019) -
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents
por: Costamagna, Andrea, et al.
Publicado: (2019) -
p130Cas Over-Expression Impairs Mammary Branching Morphogenesis in Response to Estrogen and EGF
por: Camacho Leal, Maria del Pilar, et al.
Publicado: (2012) -
Conditional ablation of p130Cas/BCAR1 adaptor protein impairs epidermal homeostasis by altering cell adhesion and differentiation
por: Camacho Leal, Maria del Pilar, et al.
Publicado: (2018)